[A case of unresectable advanced pancreatic tail cancer successfully treated with gemcitabine hydrochloride]

Gan To Kagaku Ryoho. 2005 Feb;32(2):243-5.
[Article in Japanese]

Abstract

We report a case of a 76-year-old female with unresectable advanced pancreatic tail cancer in whom systemic chemotherapy using gemcitabine hydrochloride was effective. The patient came to our hospital with a complaint of upper abdominal discomfort and was diagnosed as an advanced pancreatic tail cancer with severe vessel invasion. A curative operation was thought to be impossible, so gemcitabine hydrochloride was administered (800 mg/m2/week x 3/4 weeks). After 2 courses, the CEA, CA19-9 and SPan-1 value were decreased, and reduced tumor size was identified. Sixteen months after the first diagnosis, she died dissemination.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use*
  • Drug Administration Schedule
  • Female
  • Gemcitabine
  • Humans
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms / blood supply
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatic Neoplasms / pathology
  • Peritoneal Neoplasms / pathology
  • Quality of Life

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Gemcitabine